Potent and selective indolomorphinan antagonists of the kappa-opioid receptor

被引:86
作者
Stevens, WC [1 ]
Jones, RM [1 ]
Subramanian, G [1 ]
Metzger, TG [1 ]
Ferguson, DM [1 ]
Portoghese, PS [1 ]
机构
[1] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA
关键词
D O I
10.1021/jm0000665
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The indole moiety in the delta-opioid antagonist, naltrindole (2, NTI), was employed as a scaffold to hold an "address" for interaction with the kappa-opioid receptor. The attachment of the address to the 5'-position of the indole moiety was based on superposition of NTI upon the kappa antagonist, norbinaltorphimine (1, norBNI). A variety of cationic groups were employed as a kappa address in an effort to investigate its interaction with the anionic address subsite, Glu297, on the kappa receptor. Some of the groups that were employed for this purpose were amines, amidines, guanidines, and quaternary ammonium. Members of the series were found to have a varying degree of kappa antagonist potency and kappa selectivity when tested in smooth muscle preparations. The 5'-guanidine derivative 12a (GNTI) was the most potent member of the series and had the highest kappa selectivity ratio. GNTI was 2 times more potent and 6-10-fold more selective than norBNI (1). In general, the order of potency in the series was:guanidines > amidines similar to quaternary;ammonium > amines. The kappa antagonist potency appeared to be a function of a combination of the pK(a) and distance constraint of the cationic substituent of the ligand. Receptor binding studies were qualitatively in agreement with the pharmacological data. Molecular modeling studies on 12a suggested that the protonated N-17 and guanidinium groups of GNTI are associated with Asp138 (TM3) and Glu297 (TM6), respectively, while the phenolic hydroxyl may be involved in donor-acceptor interactions with the imidazole ring of His291. It was concluded that the basis for the high kappa selectivity of GNTI is related both to association with the nonconserved Glu297 residue and to unfavorable interactions with an equivalent position in mu- and delta-opioid receptors.
引用
收藏
页码:2759 / 2769
页数:11
相关论文
共 36 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   CATALYTIC TRANSFER HYDROGENATION [J].
BRIEGER, G ;
NESTRICK, TJ .
CHEMICAL REVIEWS, 1974, 74 (05) :567-580
[3]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[4]  
CONNOLLY M, 1995, DOCK VERSION 3 5
[5]   A 2ND GENERATION FORCE-FIELD FOR THE SIMULATION OF PROTEINS, NUCLEIC-ACIDS, AND ORGANIC-MOLECULES [J].
CORNELL, WD ;
CIEPLAK, P ;
BAYLY, CI ;
GOULD, IR ;
MERZ, KM ;
FERGUSON, DM ;
SPELLMEYER, DC ;
FOX, T ;
CALDWELL, JW ;
KOLLMAN, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5179-5197
[6]  
Dhawan BN, 1996, PHARMACOL REV, V48, P567
[7]  
FOURNIEZALUSKI MC, 1981, MOL PHARMACOL, V20, P484
[8]  
HJORTH SA, 1995, MOL PHARMACOL, V47, P1089
[9]   Mutational evidence for a common κ antagonist binding pocket in the wild-type κ and mutant μ[K303E] opioid receptors [J].
Jones, RM ;
Hjorth, SA ;
Schwartz, TW ;
Portoghese, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :4911-4914
[10]  
JONES RM, 1998, CURR OPIN DRUG DISCU, V1